We are live on ! Find out more
ALDX icon

Aldeyra Therapeutics

87 hedge funds and large institutions have $174M invested in Aldeyra Therapeutics in 2020 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 29 increasing their positions, 21 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

192% more call options, than puts

Call options by funds: $919K | Put options by funds: $315K

185% more capital invested

Capital invested by funds: $61.1M → $174M (+$113M)

67% more funds holding in top 10

Funds holding in top 10: 35 (+2)

38% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 21

14% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 21

12.46% more ownership

Funds ownership: 49.17%61.63% (+12%)

4% more funds holding

Funds holding: 8487 (+3)

Holders
87
Holders Change
+3
Holders Change %
+3.57%
% of All Funds
1.76%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.1%
New
24
Increased
29
Reduced
21
Closed
21
Calls
$919K
Puts
$315K
Net Calls
+$604K
Net Calls Change
+$250K
Name Holding Trade Value Shares
Change
Change in
Stake
DWA
76
Dorsey Wright & Associates
California
$9K +$7.97K +1,234 New
ASN
77
Advisory Services Network
Georgia
$8K +$7.2K +1,115 New
Simplex Trading
78
Simplex Trading
Illinois
$6K -$1.35K -209 -18%
Osaic Holdings
79
Osaic Holdings
Arizona
$6K +$1.87K +289 +58%
SIAP
80
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
$3K
NFG
81
Next Financial Group
Texas
$3K +$2.2K +340 New
Millennium Management
82
Millennium Management
New York
$2.48K -$1.51M -233,283 -41%
Wells Fargo
83
Wells Fargo
California
$2K -$1.8K -278 -54%
SFS
84
Sowell Financial Services
Arkansas
$1K
Federated Hermes
85
Federated Hermes
Pennsylvania
$1K +$930 +144 New
BBVA
86
Banco Bilbao Vizcaya Argentaria
Spain
-$1.31M -313,889 Closed
Acadian Asset Management
87
Acadian Asset Management
Massachusetts
-$665K -159,445 Closed
PP
88
Paloma Partners
Connecticut
-$512K -122,947 Closed
Renaissance Technologies
89
Renaissance Technologies
New York
-$332K -79,618 Closed
HF
90
HRT Financial
New York
-$324K -77,743 Closed
OMC
91
Old Mission Capital
Illinois
-$287K -68,900 Closed
SAMH
92
Shanda Asset Management Holdings
British Virgin Islands
-$129K -31,000 Closed
State of Wisconsin Investment Board
93
State of Wisconsin Investment Board
Wisconsin
-$92K -22,100 Closed
Connor, Clark & Lunn Investment Management (CC&L)
94
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
-$68K -16,346 Closed
BFM
95
Boothbay Fund Management
New York
-$50K -12,075 Closed
Bank of America
96
Bank of America
North Carolina
-$49K -11,659 Closed
Ohio Public Employees Retirement System (OPERS)
97
Ohio Public Employees Retirement System (OPERS)
Ohio
-$49K -11,647 Closed
William Blair & Company
98
William Blair & Company
Illinois
-$45K -10,850 Closed
LP
99
LMR Partners
United Kingdom
-$44K -10,540 Closed
Barclays
100
Barclays
United Kingdom
-$27K -6,451 Closed

ALDX Hedge Fund Activity: Q3 2020 in Review

87 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Aldeyra Therapeutics (ALDX) for Q3 2020, worth a combined $174M — up 185% from $61.1M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new ALDX positions and 21 closed out — a net gain of 3 holders — while 29 added to existing stakes and 21 trimmed.

The largest buyer was Perceptive Advisors, adding an estimated $20.7M. The largest seller was Prosight Management, cutting an estimated $3.41M.

  • 87 institutional investors held Aldeyra Therapeutics (ALDX) as of Q3 2020, up from 84 in Q2 2020.
  • Funds reported $174M of Aldeyra Therapeutics stock for Q3 2020, up 185% quarter-over-quarter.
  • 24 funds opened new Aldeyra Therapeutics positions in Q3 2020 and 21 closed out, a net change of +3 holders.
  • The largest Aldeyra Therapeutics buyer in Q3 2020 was Perceptive Advisors, an estimated $20.7M added.
  • The largest Aldeyra Therapeutics seller in Q3 2020 was Prosight Management, an estimated $3.41M sold.

Based on aggregated 13F filings for Q3 2020.